About Brigham Hyde
Form D filings for Atropos Health from 2022 to 2024 list Brigham Hyde as CEO and director.
Brigham Hyde first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Brigham Hyde in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Brigham Hyde works with at each company, as listed on that company's latest Form D.
Atropos Health Inc. · Form D, May 31, 2024
NS
Neil Sanghavi
Executive officer
NS
Nigam Shah
Director
MB
Matthew Bettonville
Director
MS
Mike Spadafore
Director
SG
Saurabh Gombar
Executive officer